Literature DB >> 29958330

Evolution of research ethics in a low resource setting: A case for Uganda.

Joseph Ochieng1, Erisa Mwaka1, Betty Kwagala2, Nelson Sewankambo3.   

Abstract

BACKGROUND: The globalization of clinical research in the last two decades has led to a significant increase in the volume of clinical research in developing countries. As of 2016, Uganda was the third largest destination for clinical trials in Africa. This requires adequate capacity and systems to facilitate ethical practice.
METHODS: This was a retrospective study involving review of laws, guidelines, policies and records from 1896 to date.
RESULTS: Modern medicine evolved from 1896 and by the time of Uganda's independence in 1962, a 1500 bed national referral hospital was in place and a fully-fledged medical school was established at the Makerere University. As the practice of medicine evolved in the country, so did medical research that addressed priority health issues. The growth in modern medicine was not matched with development of research infrastructure and regulatory systems. The first documented regulation of research activities was in 1970 while the first research ethics committee established in 1986 was to facilitate review of research related to the HIV/AIDs pandemic. In 1990 an Act of Parliament was passed to facilitate development and implementation of policies, hence the development of the national guidelines in 1997, training, establishment and accreditation of research ethics committees, conferences and research site monitoring.
CONCLUSION: Over the past 120 years, the implementation and structural aspects of research ethics in Uganda have evolved through 70 years of no regulation, followed by 30 years of rudimentary regulation while the last 20 years have shown significant growth in the regulatory system associated with supportive laws, institutionalization of regulatory and training processes.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Uganda; evolution; research ethics

Mesh:

Year:  2018        PMID: 29958330      PMCID: PMC6522326          DOI: 10.1111/dewb.12198

Source DB:  PubMed          Journal:  Dev World Bioeth        ISSN: 1471-8731            Impact factor:   2.294


  14 in total

1.  Pfizer accused of testing new drug without ethical approval.

Authors:  J Wise
Journal:  BMJ       Date:  2001-01-27

2.  Investigators' responsibilities for human subjects in developing countries.

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

3.  Johns Hopkins admits scientist used Indian patients as guinea pigs.

Authors:  G Mudur
Journal:  BMJ       Date:  2001-11-24

4.  THE INCIDENCE OF STRANGULATED HERNIA IN BUSOGA, UGANDA.

Authors:  P ECKHART
Journal:  East Afr Med J       Date:  1964-02

5.  THE AFRICAN LYMPHOMA: PRELIMINARY OBSERVATIONS ON RESPONSE TO THERAPY.

Authors:  D BURKITT; M S HUTT; D H WRIGHT
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

6.  Study of a mycobacterium causing skin ulceration in Uganda.

Authors:  J CLANCEY; R DODGE; H F LUNN
Journal:  Ann Soc Belg Med Trop (1920)       Date:  1962-08-31

7.  Mapping African ethical review committee activity onto capacity needs: the MARC initiative and HRWeb's interactive database of RECs in Africa.

Authors:  Carel IJsselmuiden; Debbie Marais; Douglas Wassenaar; Boitumelo Mokgatla-Moipolai
Journal:  Dev World Bioeth       Date:  2012-04-18       Impact factor: 2.294

8.  Health research ethics review and needs of institutional ethics committees in Tanzania.

Authors:  J K B Ikingura; M Kruger; W Zeleke
Journal:  Tanzan Health Res Bull       Date:  2007-09

9.  Ethics committees in India: Facing the challenges!

Authors:  Rashmi Kadam; Shashikant Karandikar
Journal:  Perspect Clin Res       Date:  2012-04

10.  Research site monitoring for compliance with ethics regulatory standards: review of experience from Uganda.

Authors:  Joseph Ochieng; Julius Ecuru; Frederick Nakwagala; Paul Kutyabami
Journal:  BMC Med Ethics       Date:  2013-06-05       Impact factor: 2.652

View more
  2 in total

1.  Researchers experience of using the regulatory affairs information system (RAIS) in strengthening research compliance in a large research program: A case study of the Infectious Diseases Institute (IDI) in Uganda.

Authors:  Sylvia Nabukenya; Stephen Okoboi; Vivian Nakate; Adelline Twimukye; Bruce Opio; Barbara Castelnuovo
Journal:  JAMIA Open       Date:  2022-07-14

Review 2.  Collection and use of human materials during TB clinical research; a review of practices.

Authors:  Joseph Ochieng; Betty Kwagala; Nelson Sewankambo
Journal:  BMC Med Ethics       Date:  2022-03-29       Impact factor: 2.834

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.